Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1987 2
1989 1
1990 1
1991 1
1992 3
1993 2
1994 2
1995 2
1996 1
1997 5
1998 3
1999 2
2000 2
2001 3
2002 3
2003 3
2004 3
2005 4
2006 8
2007 6
2008 5
2009 11
2010 9
2011 8
2012 8
2013 10
2014 9
2015 7
2016 9
2017 4
2018 10
2019 10
2020 12
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Results by year
Filters applied: . Clear all
Page 1
Improved survival with MEK inhibition in BRAF-mutated melanoma.
Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, Demidov LV, Hassel JC, Rutkowski P, Mohr P, Dummer R, Trefzer U, Larkin JM, Utikal J, Dreno B, Nyakas M, Middleton MR, Becker JC, Casey M, Sherman LJ, Wu FS, Ouellet D, Martin AM, Patel K, Schadendorf D; METRIC Study Group. Flaherty KT, et al. Among authors: ouellet d. N Engl J Med. 2012 Jul 12;367(2):107-14. doi: 10.1056/NEJMoa1203421. Epub 2012 Jun 4. N Engl J Med. 2012. PMID: 22663011 Free article. Clinical Trial.
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.
Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Casey M, Ouellet D, Martin AM, Le N, Patel K, Flaherty K. Long GV, et al. Among authors: ouellet d. N Engl J Med. 2014 Nov 13;371(20):1877-88. doi: 10.1056/NEJMoa1406037. Epub 2014 Sep 29. N Engl J Med. 2014. PMID: 25265492 Free article. Clinical Trial.
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, Hamid O, Schuchter L, Cebon J, Ibrahim N, Kudchadkar R, Burris HA 3rd, Falchook G, Algazi A, Lewis K, Long GV, Puzanov I, Lebowitz P, Singh A, Little S, Sun P, Allred A, Ouellet D, Kim KB, Patel K, Weber J. Flaherty KT, et al. Among authors: ouellet d. N Engl J Med. 2012 Nov 1;367(18):1694-703. doi: 10.1056/NEJMoa1210093. Epub 2012 Sep 29. N Engl J Med. 2012. PMID: 23020132 Free PMC article. Clinical Trial.
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
Falchook GS, Long GV, Kurzrock R, Kim KB, Arkenau TH, Brown MP, Hamid O, Infante JR, Millward M, Pavlick AC, O'Day SJ, Blackman SC, Curtis CM, Lebowitz P, Ma B, Ouellet D, Kefford RF. Falchook GS, et al. Among authors: ouellet d. Lancet. 2012 May 19;379(9829):1893-901. doi: 10.1016/S0140-6736(12)60398-5. Lancet. 2012. PMID: 22608338 Free PMC article. Clinical Trial.
MID3: Mission Impossible or Model-Informed Drug Discovery and Development? Point-Counterpoint Discussions on Key Challenges.
Krishnaswami S, Austin D, Della Pasqua O, Gastonguay MR, Gobburu J, van der Graaf PH, Ouellet D, Tannenbaum S, Visser SAG. Krishnaswami S, et al. Among authors: ouellet d. Clin Pharmacol Ther. 2020 Apr;107(4):762-772. doi: 10.1002/cpt.1788. Epub 2020 Feb 20. Clin Pharmacol Ther. 2020. PMID: 31955417 Free PMC article. No abstract available.
Healthful eating: beyond food, a global concept.
Hamelin AM, Lamontagne C, Ouellet D, Pouliot N, O'Brien HT. Hamelin AM, et al. Among authors: ouellet d. Can J Diet Pract Res. 2010 Summer;71(2):e21-7. doi: 10.3148/71.2.2010.98. Can J Diet Pract Res. 2010. PMID: 20525422 Review.
Efficacy and Safety Exposure-Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer.
Perez-Ruixo C, Ackaert O, Ouellet D, Chien C, Uemura H, Olmos D, Mainwaring P, Lee JY, Yu MK, Perez-Ruixo JJ, Smith MR, Small EJ. Perez-Ruixo C, et al. Among authors: ouellet d. Clin Cancer Res. 2020 Sep 1;26(17):4460-4467. doi: 10.1158/1078-0432.CCR-20-1041. Epub 2020 Jun 19. Clin Cancer Res. 2020. PMID: 32561663 Free article.
Population pharmacokinetics of trabectedin in adolescent patients with cancer.
Poggesi I, Valenzuela B, Ouellet D, Gonzalez M, Hillewaert V, Baruchel S, Fox E, Perez-Ruixo JJ. Poggesi I, et al. Among authors: ouellet d. Cancer Chemother Pharmacol. 2019 Oct;84(4):707-717. doi: 10.1007/s00280-019-03899-y. Epub 2019 Jul 8. Cancer Chemother Pharmacol. 2019. PMID: 31286189
157 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page